Clinical Trials Browser

Phase 2/3 × IFL protocol × Clear all

NCT07221357 2026-03-17

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03081143 2024-12-12

RAMIRIS

Phase 2/3 Active not recruiting

Gastrointestinal

Advanced Gastric or EGJ Cancer

NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Phase 2/3 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT02978313 2016-11-30

Cetuximab Monotherapy Maintenance Treatment in mCRC

Phase 2/3 Unknown

Gastrointestinal

Colorectal Neoplasms